Research Projects & Grants

For Profit Organization

  • GOG-263: Randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomy, Role: Investigator, Southwest Oncology Group, (09/2024 - 09/2025) Status: Approved
  • Southwest Oncology Group (SWOG) S1609: DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in rare tumors, Role: Investigator, Southwest Oncology Group, (12/2024 - 12/2025) Status: Approved
  • SWOG / NRG-GY009: A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer, Role: Investigator, Southwest Oncology Group, (12/2019) Status: Completed
  • SWOG -EAY131: Molecular analysis for therapy choice (MATCH), Role: Investigator, Southwest Oncology Group, (08/2019 - 08/2020) Status: Completed
  • NRG-GY018, A Phase Ill Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475) in addition to Paclitaxel and Carboplatin for Measurable Stage Ill or IVA, Stage IVB or Recurrent Endometrial Cancer (NCT # 03914612) (09/24/2019), Role: Investigator, Southwest Oncology Group, (02/2024) Status: Completed

Internal

  • The impact of air pollution on gynecologic malignancies, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (05/2024) Status: Approved
  • Percutaneous Nephrostomy Complications in Gynecologic Cancers, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (05/2024) Status: Approved
  • Investigator initiated: Conventional prophylactic regimen of oral dexamethasone versus short-course intravenous dexamethasone in preventing paclitaxel-related hypersensitivity reactions in breast and gynecologic-oncology patients: A prospective, randomized, open-label study, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (02/2024 - 01/2025) Status: Completed
  • Investigator Initiated - Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer, Role: PI, LLU Dept. of Gynecology & Obstetrics, (04/2022 - 04/2023) Status: Completed
  • Investigator initiated: Retrospective analysis to determine the incidence of Occult Cervical cancer in patients with Adenocarcinoma in situ at LLU, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (02/2019) Status: Approved
  • Collection of female reproductive tissue samples, Role: Investigator, LLU Basic Science, (01/2015 - 01/2016) Status: Completed
  • Compassionate use of everolimus: Individual patient program (IPP) for treatment of recurrent progressive clear cell endocervical cancer with everolimus, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, Status: Completed
  • LLU Cancer Center biospecimen laboratory - specimens collection protocol, Role: Investigator, LLU Cancer Institute, (09/2024 - 09/2025) Status: Approved
  • Evaluating DNA recovered from the fluids collected during a routine Papanicolaou (Pap) test to detect ovarian and endometrial cancer using genetic analysis, Role: Investigator, LLU Dept. of Pathology & Human Anatomy, (12/2024 - 12/2025) Status: Approved